Covered recipient · General Payments record

MEGHA SHAH

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI: 1437393352
CMS profile: 20458
Location: FLEMINGTON, NJ

General Payments · PY2018–2024

$13,174.11

Reported across 347 records
CMS publication 2026-01-23

Latest program year · PY2024

$6,070.54

86 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Consulting Fee	$3,710.00	2
Food and Beverage	$1,363.54	74
Long term medical supply or device loan	$997.00	10

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Alnylam Pharmaceuticals Inc.	$2,300.00	1
Daiichi Sankyo Inc.	$1,464.80	4
NOVARTIS PHARMACEUTICALS CORPORATION	$1,054.76	13
Acerta Pharma LLC	$141.83	8
GENZYME CORPORATION	$115.68	5
ABBVIE INC.	$76.25	5
BeiGene USA, Inc.	$57.38	3
Regeneron Healthcare Solutions, Inc.	$56.90	3
Lilly USA, LLC	$56.55	3
Gilead Sciences, Inc.	$52.86	3
Janssen Biotech, Inc.	$51.48	3
Astellas Pharma US Inc	$42.05	2
PFIZER INC.	$39.83	2
ARRAY BIOPHARMA INC	$39.70	2
EISAI INC.	$36.21	2
GlaxoSmithKline, LLC.	$34.97	2
SpringWorks Therapeutics, Inc.	$33.64	2
E.R. Squibb & Sons, L.L.C.	$32.94	2
Celgene Corporation	$32.15	2
Incyte Corporation	$30.78	2
Tempus AI, Inc	$29.17	1
Genentech USA, Inc.	$22.16	1
Genmab U.S., Inc.	$21.52	1
TAIHO ONCOLOGY, INC.	$21.18	1
SERVIER PHARMACEUTICALS LLC	$18.87	1
Alexion Pharmaceuticals, Inc.	$18.77	1
Janssen Pharmaceuticals, Inc	$18.69	1
Celltrion USA Inc.	$18.69	1
Takeda Pharmaceuticals U.S.A., Inc.	$18.38	1
Fresenius Kabi USA, LLC	$17.15	1
AVEO Pharmaceuticals, Inc.	$16.94	1
Karyopharm Therapeutics Inc.	$16.92	1
Ipsen Biopharmaceuticals, Inc	$16.91	1
EMD Serono, Inc.	$16.90	1
Kyowa Kirin, Inc.	$16.85	1
Cumberland Pharmaceuticals, Inc.	$15.42	1
Stemline Therapeutics Inc.	$15.26	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$606.84	44
PY2019	$793.32	53
PY2020	$405.92	17
PY2021	$478.78	29
PY2022	$766.83	46
PY2023	$4,051.88	72
PY2024	$6,070.54	86

Payment records · PY2024 (86)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$14.25	02/23/2024	Food and Beverage	Undisputed	01/23/2026	1106065116	CMS
ABBVIE INC.	$13.45	04/04/2024	Food and Beverage	Undisputed	01/23/2026	1106065118	CMS
ABBVIE INC.	$16.72	07/25/2024	Food and Beverage	Undisputed	01/23/2026	1106065120	CMS
ABBVIE INC.	$14.83	08/19/2024	Food and Beverage	Undisputed	01/23/2026	1106065122	CMS
ABBVIE INC.	$17.00	09/11/2024	Food and Beverage	Undisputed	01/23/2026	1106065124	CMS
Alexion Pharmaceuticals, Inc.	$18.77	05/17/2024	Food and Beverage	Undisputed	01/23/2026	1094015725	CMS
Alnylam Pharmaceuticals Inc.	$2,300.00	06/13/2024	Consulting Fee	Undisputed	01/23/2026	1125827979	CMS
ARRAY BIOPHARMA INC	$20.50	02/21/2024	Food and Beverage	Undisputed	01/23/2026	1131194501	CMS
ARRAY BIOPHARMA INC	$19.20	08/28/2024	Food and Beverage	Undisputed	01/23/2026	1131901031	CMS
Astellas Pharma US Inc	$23.79	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1139355041	CMS
Astellas Pharma US Inc	$18.26	06/27/2024	Food and Beverage	Undisputed	01/23/2026	1139368495	CMS
AstraZeneca Pharmaceuticals LP	$30.50	01/17/2024	Food and Beverage	Undisputed	01/23/2026	1105863900	CMS
AstraZeneca Pharmaceuticals LP	$0.27	01/24/2024	Food and Beverage	Undisputed	01/23/2026	1105678279	CMS
AstraZeneca Pharmaceuticals LP	$18.53	01/25/2024	Food and Beverage	Undisputed	01/23/2026	1105277614	CMS
AstraZeneca Pharmaceuticals LP	$16.90	01/26/2024	Food and Beverage	Undisputed	01/23/2026	1104708981	CMS
AstraZeneca Pharmaceuticals LP	$19.51	02/02/2024	Food and Beverage	Undisputed	01/23/2026	1104555902	CMS
AstraZeneca Pharmaceuticals LP	$19.25	02/29/2024	Food and Beverage	Undisputed	01/23/2026	1104308056	CMS
AstraZeneca Pharmaceuticals LP	$18.68	10/01/2024	Food and Beverage	Undisputed	01/23/2026	1104665979	CMS
AstraZeneca Pharmaceuticals LP	$18.19	11/15/2024	Food and Beverage	Undisputed	01/23/2026	1105363099	CMS
Aveo Pharmaceuticals, Inc.	$16.94	11/21/2024	Food and Beverage	Undisputed	01/23/2026	1143482315	CMS
BeiGene USA, Inc.	$20.09	05/28/2024	Food and Beverage	Undisputed	01/23/2026	1120864274	CMS
BeiGene USA, Inc.	$18.12	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1120864272	CMS
BeiGene USA, Inc.	$19.17	10/14/2024	Food and Beverage	Undisputed	01/23/2026	1120864270	CMS
Celgene Corporation	$15.00	02/29/2024	Food and Beverage	Undisputed	01/23/2026	1101145331	CMS
Celgene Corporation	$17.15	07/23/2024	Food and Beverage	Undisputed	01/23/2026	1101145345	CMS
Celltrion USA Inc.	$18.69	10/29/2024	Food and Beverage	Undisputed	01/23/2026	1075858021	CMS
Cumberland Pharmaceuticals, Inc.	$15.42	03/15/2024	Food and Beverage	Undisputed	01/23/2026	1146403560	CMS
Daiichi Sankyo Inc.	$9.88	02/06/2024	Food and Beverage	Undisputed	01/23/2026	1089481109	CMS
Daiichi Sankyo Inc.	$1,410.00	02/21/2024	Consulting Fee	Undisputed	01/23/2026	1089481043	CMS
Daiichi Sankyo Inc.	$19.93	06/20/2024	Food and Beverage	Undisputed	01/23/2026	1089481165	CMS
Daiichi Sankyo Inc.	$24.99	12/19/2024	Food and Beverage	Undisputed	01/23/2026	1089481015	CMS
E.R. Squibb & Sons, L.L.C.	$14.98	04/22/2024	Food and Beverage	Undisputed	01/23/2026	1101485331	CMS
E.R. Squibb & Sons, L.L.C.	$17.96	08/26/2024	Food and Beverage	Undisputed	01/23/2026	1101485644	CMS
Eisai Inc.	$16.36	03/13/2024	Food and Beverage	Undisputed	01/23/2026	1110765035	CMS
Eisai Inc.	$19.85	10/17/2024	Food and Beverage	Undisputed	01/23/2026	1110765037	CMS
EMD Serono, Inc.	$16.90	03/21/2024	Food and Beverage	Undisputed	01/23/2026	1120227442	CMS
Fresenius Kabi USA, LLC	$17.15	01/04/2024	Food and Beverage	Undisputed	01/23/2026	1146948427	CMS
Genentech USA, Inc.	$22.16	12/11/2024	Food and Beverage	Undisputed	01/23/2026	1133067922	CMS
Genmab U.S., Inc.	$21.52	08/30/2024	Food and Beverage	Undisputed	01/23/2026	1126829668	CMS
GENZYME CORPORATION	$17.32	04/22/2024	Food and Beverage	Undisputed	01/23/2026	1139832785	CMS
GENZYME CORPORATION	$23.14	06/25/2024	Food and Beverage	Undisputed	01/23/2026	1139832845	CMS
GENZYME CORPORATION	$24.83	07/09/2024	Food and Beverage	Undisputed	01/23/2026	1139832853	CMS
GENZYME CORPORATION	$23.10	08/21/2024	Food and Beverage	Undisputed	01/23/2026	1139832873	CMS
GENZYME CORPORATION	$27.29	09/05/2024	Food and Beverage	Undisputed	01/23/2026	1139832829	CMS
Gilead Sciences, Inc.	$17.88	03/11/2024	Food and Beverage	Undisputed	01/23/2026	1133794431	CMS
Gilead Sciences, Inc.	$17.62	05/03/2024	Food and Beverage	Undisputed	01/23/2026	1133794433	CMS
Gilead Sciences, Inc.	$17.36	11/07/2024	Food and Beverage	Undisputed	01/23/2026	1133794435	CMS
GlaxoSmithKline, LLC.	$17.35	04/04/2024	Food and Beverage	Undisputed	01/23/2026	1115980741	CMS
GlaxoSmithKline, LLC.	$17.62	08/02/2024	Food and Beverage	Undisputed	01/23/2026	1116272886	CMS
Incyte Corporation	$14.16	04/25/2024	Food and Beverage	Undisputed	01/23/2026	1141317761	CMS
Incyte Corporation	$16.62	09/25/2024	Food and Beverage	Undisputed	01/23/2026	1141176164	CMS
Ipsen Biopharmaceuticals, Inc	$16.91	03/22/2024	Food and Beverage	Undisputed	01/23/2026	1091954437	CMS
Janssen Biotech, Inc.	$19.22	02/08/2024	Food and Beverage	Undisputed	01/23/2026	1078352835	CMS
Janssen Biotech, Inc.	$17.81	05/06/2024	Food and Beverage	Undisputed	01/23/2026	1078352588	CMS
Janssen Biotech, Inc.	$14.45	06/07/2024	Food and Beverage	Undisputed	01/23/2026	1078352718	CMS
Janssen Pharmaceuticals, Inc	$18.69	02/02/2024	Food and Beverage	Undisputed	01/23/2026	1078090420	CMS
Karyopharm Therapeutics Inc.	$16.92	07/05/2024	Food and Beverage	Undisputed	01/23/2026	1145533567	CMS
Kyowa Kirin, Inc.	$16.85	01/31/2024	Food and Beverage	Undisputed	01/23/2026	1127037332	CMS
Lilly USA, LLC	$16.76	03/07/2024	Food and Beverage	Undisputed	01/23/2026	1135199561	CMS
Lilly USA, LLC	$20.87	08/14/2024	Food and Beverage	Undisputed	01/23/2026	1135188135	CMS
Lilly USA, LLC	$18.92	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1135181420	CMS
Novartis Pharmaceuticals Corporation	$16.43	01/11/2024	Food and Beverage	Undisputed	01/23/2026	1087293503	CMS
Novartis Pharmaceuticals Corporation	$99.70	01/18/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293513	CMS
Novartis Pharmaceuticals Corporation	$14.22	02/14/2024	Food and Beverage	Undisputed	01/23/2026	1087293505	CMS
Novartis Pharmaceuticals Corporation	$99.70	02/16/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293515	CMS
Novartis Pharmaceuticals Corporation	$27.11	02/27/2024	Food and Beverage	Undisputed	01/23/2026	1087293507	CMS
Novartis Pharmaceuticals Corporation	$99.70	03/15/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293517	CMS
Novartis Pharmaceuticals Corporation	$99.70	04/18/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293519	CMS
Novartis Pharmaceuticals Corporation	$99.70	05/16/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293521	CMS
Novartis Pharmaceuticals Corporation	$99.70	06/13/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293523	CMS
Novartis Pharmaceuticals Corporation	$99.70	07/15/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293525	CMS
Novartis Pharmaceuticals Corporation	$99.70	08/23/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293509	CMS
Novartis Pharmaceuticals Corporation	$99.70	09/27/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293511	CMS
Novartis Pharmaceuticals Corporation	$99.70	10/17/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087293527	CMS
PFIZER INC.	$18.85	03/26/2024	Food and Beverage	Undisputed	01/23/2026	1131291139	CMS
PFIZER INC.	$20.98	08/01/2024	Food and Beverage	Undisputed	01/23/2026	1131783026	CMS
Regeneron Healthcare Solutions, Inc.	$14.68	03/29/2024	Food and Beverage	Undisputed	01/23/2026	1114167885	CMS
Regeneron Healthcare Solutions, Inc.	$22.63	06/17/2024	Food and Beverage	Undisputed	01/23/2026	1114167887	CMS
Regeneron Healthcare Solutions, Inc.	$19.59	12/12/2024	Food and Beverage	Undisputed	01/23/2026	1114167889	CMS
SERVIER PHARMACEUTICALS LLC	$18.87	07/31/2024	Food and Beverage	Undisputed	01/23/2026	1147261844	CMS
SpringWorks Therapeutics, Inc.	$15.01	01/22/2024	Food and Beverage	Undisputed	01/23/2026	1085808031	CMS
SpringWorks Therapeutics, Inc.	$18.63	09/03/2024	Food and Beverage	Undisputed	01/23/2026	1085808033	CMS
Stemline Therapeutics Inc.	$15.26	10/11/2024	Food and Beverage	Undisputed	01/23/2026	1142962089	CMS
TAIHO ONCOLOGY, INC.	$21.18	08/27/2024	Food and Beverage	Undisputed	01/23/2026	1137936983	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$18.38	11/06/2024	Food and Beverage	Undisputed	01/23/2026	1144967089	CMS
Tempus AI, Inc	$29.17	06/24/2024	Food and Beverage	Undisputed	01/23/2026	1150174204	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.